StockData
Zivo Bioscience, Inc. logo

Zivo Bioscience, Inc. (ZIVO) stock

ZIVOOTCBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q3 FY2025, quarter ended Sep 30, 2025Last filing: 10-Q on Nov 14, 2025Score 1/30
$6.80+0.30 (+4.62%)

Close on Oct 19, 2026Market cap $25.96MP/E –Yield –

Zivo Bioscience price to sales ratio

The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.

Zivo Bioscience's price to sales ratio was 124.7× on Oct 19, 2026, against 305.5× a year earlier. Over the last 2 years it ranged from 60.5× to 465.2×, with a median of 192.5×.

Price to Sales Ratio at the end of each year

PeriodPeriod endValueChange (pts)
2026Oct 19, 2026124.7×−34.8
2025Dec 31, 2025159.5×−214.7
2024Jul 31, 2024374.2×+242.3
2023Dec 29, 2023131.9×–

More Zivo Bioscience figures

See a number that looks wrong?